Video
Maria Teresa Abreu (University of Miami, USA) discussed some new strategies to design clinical trials.
Theresa Pizarro, (Case Western Reserve University School of Medicine) discussed the roles of epithelial barrier’s cytokines, gut microbiome and Gasdermin in IBD patients.
Sudarshen Paramsothy (University of New South Wales, Australia) discussed the controversials about FMT in IBD patients.
Herbert Tilg (University Innsbruck, Austria) discussed the relationship between Inflammatory Bowel Diseases and gut microbiome.
Niall Hyland (University College Cork) discussed the research on gut brain axis and the potential role of psychobiotics.
Simone Guglielmetti (University of Milan) discusses the use of inactivated microbes as alternative to live probiotics.
Patrice Cani (Université catholique de Louvain) discusses the role of Akkermansia muciniphila in the gut barrier.
Patrice Cani (Université catholique de Louvain) discusses the future of Akkermansia municiphila.
Philippe Lagella of the Instituit National de la Rcherche Agronomique - France, talks about the increasing interest in Faecalibacterium prausnitzii and its possible use.
Dr. Raanan Shamir discusses the role that the intestinal microbiota plays in the development of celiac disease.
